Nicox S.A. (ALCOX.PA)

EUR 0.3

(7.19%)

EBITDA Summary of Nicox S.A.

  • Nicox S.A.'s latest annual EBITDA in 2023 was -16.23 Million EUR , up 10.29% from previous year.
  • Nicox S.A.'s latest quarterly EBITDA in 2023 FY was N/A , up 10.29% from previous quarter.
  • Nicox S.A. reported an annual EBITDA of -18.1 Million EUR in 2022, down -253.41% from previous year.
  • Nicox S.A. reported an annual EBITDA of -15.96 Million EUR in 2021, up 183.55% from previous year.
  • Nicox S.A. reported a quarterly EBITDA of N/A for 2023 FY, up 10.29% from previous quarter.
  • Nicox S.A. reported a quarterly EBITDA of -4172.00 EUR for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Nicox S.A. (2023 - 2019)

Historical Annual EBITDA of Nicox S.A. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -16.23 Million EUR 10.29%
2022 -18.1 Million EUR -253.41%
2021 -15.96 Million EUR 183.55%
2020 -14.12 Million EUR 22.97%
2019 -18.33 Million EUR 0.0%

Peer EBITDA Comparison of Nicox S.A.

Name EBITDA EBITDA Difference
European Medical Solutions 59 Thousand EUR 27622.034%
FERMENTALG -10.51 Million EUR -54.5%
PHAXIAM Therapeutics S.A. -22.93 Million EUR 29.184%